Loading…
Daiichi Life Group Inc. offered to buy the remainder of Challenger Ltd. that it doesn’t already own, in a takeover bid that valued the Australian firm at around A$7.9 billion ($5.5 billion).
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.